SOLACI Symposium at AGC Cardiology Congress

Simposio SOLACI en el Congreso de Cardiología de la AGCWe have the pleasure to announce SOLACI will be taking part in the Annual Meeting of the Guatemalan Cardiology Association with a joint symposium chaired by doctors Alfaro Marchena Noriega (Panama) and Francisco Somoza (Honduras).

 

The event will be held on Thursday the 4th of October 2018, from 3 to 5:30 pm, at Camino Real Hotel in Guatemala City, and will be discussing the following topics:

 

  • Coronary Intervention in Elderly Patients
  • TAVR State of the Art
  • Hybrid Coronary Revascularization: how feasible is it?
  • Interesting Cases: percutaneous intervention with different comorbidities

 

AGC Cardiology Congress will take place on October 4 and 5, at the Westin Camino Real Hotel in Guatemala City.

 

More information

 

More articles by this author

Check out the best images of the El Salvador 2024 Sessions

Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....